FLT3L-based drug conjugate effectively targets chemoresistant leukemia stem cells in acute myeloid leukemia.
FLT3L-based drug conjugate effectively targets chemoresistant leukemia stem cells in acute myeloid leukemia. Cell Rep Med. 2025 Sep 19; 102365.